GCGaetano Crepaldi

Gaetano Crepaldi

*This is an algorithmically generated author record based on publicly available information.

Gaetano Crepaldi has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Metabolic syndrome

    by Stefania Maggi, Gaetano Crepaldi

    Two of the major determinants of rising healthcare costs in Western society are represented by population ageing, which is accompanied by a parallel increase in age-associated diseases and disabilities, as well as by obesity and its related comorbidities. Many studies have shown that selected risk factors such as impaired glucose tolerance, atherogenic dyslipidemia, and hypertension co-occur to a greater degree than that expected by chance alone in obese individuals (especially in those with central obesity). Their co-occurrence has been defined as ‘metabolic syndrome’, a multifactorial disease of substantial heterogeneity, a major risk factor for type 2 diabetes mellitus, atherosclerotic cardiovascular disease (CVD) and, in the older population, also for cancer, cognitive decline, functional dependence, depression, low quality of life, and mortality. Identifying and treating metabolic syndrome (MS) is thus of vital importance because it could lead to a significant decrease in the burden of morbidity and mortality in older patients.

  • Ten-year hip fracture incidence rate trends in older residents in a large Northern Italian region, 2001–2010

    by N. Gennaro, U. Fedeli, M. Noale, A. Marton, M. Saugo, G. Crepaldi, S. Maggi


    • 1 June 2012
      • Vol. 24, 35-42

    Discussing end-of-life care issues with terminally ill patients and their relatives: comparisons among physicians, nurses and psychologists.

    by Mario Iasevoli, Valter Giantin, Alberto Voci, Elisabetta Valentini, Anna Zurlo, Stefania Maggi, Paola Siviero, Graziella Orru, Gaetano Crepaldi, Renzo Pegoraro, et al.

    The aim of this study was to analyse the end-of-life topics most frequently discussed by Italian physicians, nurses and psychologists with terminally ill patients and their relatives. Findings were compared with the levels of communication reported by physicians in other countries involved in the EURELD research project, in Europe and elsewhere. An ad hoc questionnaire was prepared to measure levels of communication and administered to 716 professionals (181 physicians, 454 nurses and 81 psychologists) employed in geriatric hospital wards, hospices and nursing homes, or registered with professional associations in the Veneto and Trentino Alto-Adige regions of north-east Italy. Statistical analyses (frequency analysis, multivariate logistic regression) were conducted on data from questionnaires returned by standard mail or email. Communication levels vary for the various end-of-life issues which physicians, nurses and psychologists are required to discuss and the individuals with whom they deal. Italian physicians are more communicative with relatives than with patients, whereas psychologists tend to discuss these problems more with patients than with members of their families. Nurses behave in much the same way with both patients and relatives. By comparison with their colleagues elsewhere in Europe, Italian physicians reveal more evident differences in their willingness to discuss end-of-life issues, depending on whether they are communicating with patients or relatives. Having received bio-ethical training helps physicians communicate with their patients. Communicating is a fundamental part of providing care for terminally ill patients and support for their families. The patient care process involves several kinds of professionals, who are all increasingly called upon to be prepared to discuss the end of a patient's life, and to develop a therapeutic relationship which includes communicating without evading any of the aspects (and problems) relating to this crucial final stage of an individual's life.


  • Quantitative Ultrasound Criteria for Risk Stratification in Clinical Practice: A Comparative Assessment

    by Marianna Noale, Stefania Maggi, Stefano Gonnelli, Federica Limongi, Silvia Zanoni, Sabina Zambon, Renzo Rozzini, Gaetano Crepaldi


  • Physicians’ and nurses’ experiences of end-of-life decision-making in geriatric settings

    by V. Giantin, P. Siviero, M. Simonato, M. Iasevoli, V. Pengo, M. Andrigo, M. Storti, E. Valentini, R. Pegoraro, S. Maggi, et al.

    In Italy there is a paucity of empirical data on practices concerning endof- life decisions (ELDs) in geriatrics. We aimed to investigate the frequency and characteristics of ELDs made by Italian physicians and nurses in the geriatric setting.\ud In 2009, an anonymous questionnaire was sent to 54 geriatric units, 21 hospices, and 382 nursing homes in the Veneto and Trentino Alto Adige regions, and to professionals in the area who are members of the Italian Gerontology and Geriatrics Association.This paper reports the results of 552 questionnaires answered by 171 physicians, 368 nurses and 13 professionals who did not state their profession. Death was preceded by decisions to start or continue treatments likely to prolong the patients' life in 51.3% of cases. The proportion of deaths preceded by a decision to end life (DEL) was 20.8%; 18% of DELs concerned non-treatment decisions. There were 9 cases of ending of life without patient's explicit request. No cases of doctor-assisted suicide were reported, while there were 2 cases of euthanasia, one reported by a physician and one by a nurse. In geriatrics, DELs often precede the deaths of terminally-ill Italian patients. Nurses report making DELs more often than physicians, especially in incompetent patients. Continuous deep sedation was adopted by 39.5% of the Italian physicians for deaths not occurring suddenly and unexpectedly. Our report on physicians' and nurses' experiences of ELD making in geriatric settings can offer a valuable contribution to the current debate on end-of-life treatment, an issue that goes beyond national border


  • Association of single measurement of estimated glomerular filtration rate and non-quantitative dipstick proteinuria with all-cause and cardiovascular mortality in the elderly. Results from the Progetto Veneto Anziani (Pro.V.A.) Study

    by Sabina Zambon, Stefania Maggi, Silvia Zanoni, Giovanna Romanato, Marianna Noale, Maria Chiara Corti, Leonardo Sartori, Estella Musacchio, Giovannella Baggio, Giuseppe Sergi, et al.


  • Open Access

    Development and Validation of a New Questionnaire for the Evaluation of Upper Gastrointestinal Symptoms in the Elderly Population: A Multicenter Study

    by Alberto Pilotto, Stefania Maggi, Marianna Noale, Marilisa Franceschi, Giancarlo Parisi, Gaetano Crepaldi, on behalf of the IPOD Investigators

    Several diagnostic questionnaires for evaluating upper gastrointestinal symptoms have been described; none of these, however, has been validated in older individuals. To develop and validate a diagnostic tool for evaluating upper gastrointestinal symptoms in older patients. A cohort of 206 older patients who underwent a upper gastrointestinal endoscopy (development cohort) was used for developing a 15-item upper gastrointestinal symptom questionnaire for the elderly population (UGISQUE), including five symptom clusters: (a) abdominal pain syndrome, (b) reflux syndrome, (c) indigestion syndrome, (d) bleeding, and (e) nonspecific symptoms. The questionnaire was then validated in a cohort of 326 older patients selected from those who underwent an upper gastrointestinal endoscopy in 15 gastroenterological centers in Italy (validation cohort). The endoscopic diagnoses in the development and validation cohorts were esophagitis (E) 15.5% and 29.4%, erosive gastritis (EG) 24.8% and 24.8%, peptic ulcer (PU) 26.2% and 14.7%, and without organic lesions (WOL) 31.0% and 33.5%, respectively. In both the cohorts, patients with upper gastrointestinal disorders showed significantly more symptoms than WOL patients. The predictive value of UGISQUE for any pathological condition (E, EG, or PU) was good, with areas under the receiver-operating characteristic curve of .80, 95% confidence interval (CI) 0.743–0.864, and of .78, 95% CI 0.73–0.83, in the development and validation cohorts, respectively. The accuracy of UGISQUE was significantly higher than that for the individual clusters of symptoms in predicting the presence of E (p = .004), PU (p < .0001), or any pathological condition (p < .0001). UGISQUE is an accurate diagnostic tool for evaluating symptoms in elderly patients with upper gastrointestinal disorders.


    • 1 January 2009
      • Vol. 32, 2-5

    Epidemiologic link between osteoporosis and cardiovascular disease.

    by G Crepaldi, S Maggi

    Osteoporosis and cardiovascular disease (CVD) are major public health problems, leading to increased morbidity and mortality. Although historically considered as independent conditions, clinical and epidemiological studies indicate that there are common pathophysiological mechanisms underlying these diseases. In addition to menopause and advanced age, risk factors for CVD, such as obesity and diabetes, have also been associated with osteoporosis. Dyslipidemia, oxidative stress, inflammation, hyperhomocystinemia are associated to bone remodeling impairment and to the atherosclerotic process and might explain, in part, the co-existence of osteoporosis and CVD.


  • Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management

    by G. Crepaldi, M. Carruba, M. Comaschi, S. Del Prato, G. Frajese, G. Paolisso

    Dipeptidyl peptidase 4 (DPP-4) inhibitors are a new pharmacological class of drugs for treating Type 2 diabetes. They improve the capacity of the organism to control glycemia by increasing the levels of active incretins. Their mechanism of action is thus radically different from those of other anti-diabetic drugs currently available. DDP-4 inhibitors use a physiological mechanism to control hyperglycemia, by stimulating the secretion of insulin from β-cells, decreasing the secretion of glucagon from pancreatic α-cells, and at the same time reducing the production of glucose by the liver. DDP-4 inhibitors have shown significant efficacy in maintaining reduced levels of glycosylated hemoglobin for up to 1 year. In vitro and animal studies have shown that they can inhibit apoptosis of β-cells and favor their regeneration and differentiation. The oral DPP-4 inhibitors vildagliptin, sitagliptin, and saxagliptin are efficacious both alone and in association with other oral anti-diabetic agents and may be administered in a single daily dose. Lastly, they have substantial advantages with respect to other anti-diabetic drugs, since they involve a low risk of hypoglycemia and do not affect body weight.


    • 1 January 2007
      • Vol. 30, 42-7

    Osteoporosis and body composition.

    by G Crepaldi, G Romanato, Paolo Tonin, S Maggi

    The Epidemiologic Study on the Prevalence of Osteoporosis in Italy showed that the prevalence of osteoporosis among women and men aged 60 yr and over is 22.8% and 14.5%, respectively, giving rise to about 80,000 new fractures a yr. Sarcopenia is considered to be one of the main features of the aging process. It is characterized by a reduction in muscle mass and muscle strength, and affects women more than men. It is associated with a increased risk of fractures consequent upon a greater predisposition to falls, but also to the lack of bone remodeling due to reduced muscle mechanical strength. Muscle strength determines quality bone modifications such as density, strength, and microarchitecture. Variations in the ratios of cortical and muscle areas give rise to various types of osteoporosis, with different risks of fracture. Bone mineral density increases with body fat mass, and obesity has a protective effect against osteoporosis. This protective effect is explained by a combination of hormonal (peripheral aromatization of androgens to estrogens in adipose tissue) and mechanical factors (on weight-bearing bone sites), but the hormone leptin also probably mediates fat and bone mass. Serum leptin levels are closely related to body fat mass, and some findings suggest the peripheral effect of leptin, which exerts estrogenic effects, enhancing osteoblastic differentiation and inhibiting late adipocytic differentiation. The overall effect of leptin on bone results from a balance between negative central effects and positive direct peripheral effects, according to serum leptin levels.